Bg pattern

KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Ketotifeno Dermogen 0,25 mg/ml colirio en solución en envase unidosis

Lea todo el prospecto detenidamente antes de empezar a usar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico, farmacéutico o enfermero.
  • Este medicamento se le ha recetado solamente a usted y no debe dárselo a otras personas, aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico, farmacéutico o enfermero, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto

  1. Qué es Ketotifeno Dermogen y para qué se utiliza
  2. Qué necesita saber antes de empezar a usar Ketotifeno Dermogen
  3. Cómo usar Ketotifeno Dermogen
  4. Posibles efectos adversos
    1. Conservación de Ketotifeno Dermogen
  1. Contenido del envase e información adicional

1. Qué es Ketotifeno Dermogen y para qué se utiliza

Ketotifeno Dermogen contiene el principio activo ketotifeno, que es una sustancia antialérgica. Ketotifeno Dermogen se usa para tratar los síntomas oculares de la conjuntivitis alérgica estacional.

Debe consultar a un médico si empeora o si no mejora.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a usar Ketotifeno Dermogen

No use Ketotifeno Dermogen :

  • si es alérgico al ketotifeno o a cualquiera de los demás componentes de este medicamento (incluidos en la sección 6).

Advertencias y precauciones

Consulte a su médico,farmacéutico o enfermero antes de empezar a usar Ketotifeno Dermogen

Uso de Ketotifeno Dermogen con otros medicamentos

Si necesita aplicarse en los ojos cualquier otro medicamento además de Ketotifeno Dermogen, espere como mínimo 5 minutos entre la aplicación de cada producto.

Informe a su médico o farmacéutico si está utilizando, ha utilizado recientemente o podría tener que utilizar cualquier otro medicamento. Esto es especialmente importante en el caso de medicamentos que se usan para tratar:

  • depresión
  • alergia (por ejemplo antihistamínicos)

Uso de Ketotifeno Dermogen con alimentos, bebidas y alcohol

Ketotifeno Dermogen puede aumentar los efectos del alcohol.

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Ketotifeno Dermogen se puede usar durante la lactancia.

Conducción y uso de máquinas

Ketotifeno Dermogen puede causar visión borrosa o somnolencia. No conduzca ni utilice máquinas hasta que hayan desaparecido estos efectos.

3. Cómo usar Ketotifeno Dermogen

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

La dosis recomendada para adultos, ancianos y niños (de 3 años o más), es de una gota en el ojo (u ojos) afectado(s) dos veces al día (por la mañana y por la noche).

Un envase unidosis contiene la cantidad de solución suficiente para tratar ambos ojos en una

aplicación.

Instrucciones de uso:

  1. Lávese las manos.
  2. Abra el envase blíster y saque el bloque de envases unidosis.
  3. Separe un envase unidosis de la tira (Fig. 1).
  4. Guarde los envases unidosis restantes de nuevo en el blíster y cierre el blíster doblando el borde del mismo. Guarde el envase blíster en el cartón.
  5. Abra el envase unidosis mediante torsión de su extremo superior. Tras abrir el envase no toque la punta del cuentagotas (Fig. 2).
  6. Incline la cabeza hacia atrás (Fig. 3).
  7. Tire del párpado inferior hacia abajo con el dedo y sujete el envase con la otra mano. Apriete el envase de forma que caiga una gota en el ojo (Fig. 4).
  8. Cierre los ojos y presione con la punta de un dedo el ángulo interior del ojo durante 1-2 minutos aproximadamente. Esto previene que la gota baje por el conducto lagrimal hasta la garganta y la mayor parte de la gota permanecerá en el ojo (Fig. 5). Si es necesario, repita los pasos 6 al 8 con el otro ojo.
  9. Desechar el envase después de su uso.

Viales con líquido, mano aplicando gotas en ojo, perfil de cabeza y mano sujetando párpado inferior con gotas oculares

Fig.1 Fig. 2 Fig.3 Fig. 4 Fig.5

Si tiene cualquier otra duda sobre el uso de este producto, pregunte a su médico, farmacéutico o enfermero.

Si usa más Ketotifeno Dermogen del que debe

No hay peligro alguno si toma Ketotifeno Dermogen por vía oral accidentalmente, ni tampoco si más de una gota cae accidentalmente en su ojo. En caso de duda, consulte con su médico. Asimismo, en caso de sobredosis o ingestión accidental, puede usted consultar al Servicio de Información Toxicológica Tel.: 91 562 04 20.

Si olvidó usar Ketotifeno Dermogen

Si olvidó usar Ketotifeno Dermogen debe aplicarse el tratamiento tan pronto se acuerde. Después vuelva a su régimen habitual de tratamiento. No tome una dosis doble para compensar las dosis olvidadas.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Se han notificado los siguientes efectos adversos.

Frecuentes (afectan a menos de 1 de cada 10 pacientes)

  • irritación en el ojo o dolor en el ojo
  • inflamación en el ojo

Poco frecuentes (afectan a menos de 1 de cada 100 pacientes)

  • visión borrosa cuando se aplican las gotas en el ojo
  • sequedad en el ojo
  • alteración en el párpado
  • conjuntivitis
  • sensibilidad aumentada de los ojos a la luz
  • hemorragia visible en la zona blanca del ojo
  • dolor de cabeza
  • somnolencia
  • erupción (que puede también producir picor)
  • eczema (picor, enrojecimiento, erupción con escozor)
  • sequedad de boca
  • reacción alérgica (incluyendo hinchazón de la cara y los párpados) e incremento de la severidad de una condición alérgica ya existente como asma y eczema

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Ketotifeno Dermogen

No requiere condiciones especiales de conservación.

Mantener este medicamento fuera de la vista y del alcance de los niños.

Mantener el envase unidosis en la bolsa de aluminio.

Una vez abierto, el contenido del envase unidosis se debe usar inmediatamente y no guardarlo.

No utilice este medicamento después de la fecha de caducidad que aparece en la caja después de CAD. La fecha de caducidad es el último día del mes que se indica.

No utilice este medicamento si observa indicios visibles de deterioro.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Ketotifeno Dermogen

El principio activo es ketotifeno (en forma de fumarato). Cada ml contiene 0,345 mg de ketotifeno fumarato, que corresponde a 0,25 mg de ketotifeno.

Los demás componentes son glicerol (E422), hidróxido de sodio (E524), ácido fosfórico y agua purificada.

Aspecto del producto y contenido del envase

Ketotifeno Dermogen es una solución incolora. Cada envase unidosis contiene 0,4 ml.

Ketotifeno Dermogen se presenta en envases que contienen 5, 10 y 20 envases unidosis.

Puede que solamente estén comercializados algunos tamaños de envases.

Titular de la autorización de comercialización y responsable de la fabricación

Titular de la autorización de comercialización

NUTRA ESSENTIAL OTC, S.L.

La Granja, 1

28108 Alcobendas Madrid

Responsablesde la fabricación

Unolab Manufacturing S.L.

Avenida de las Flores nº 6

28970 Humanes de Madrid (Madrid). España

o

Farmalider S.A.

C/Aragoneses2

28108 Alcobendas (Madrid) España

Fecha de la última revisión de este prospecto:Julio 2017

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Online doctors for KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€61

Get KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?

KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?

The active ingredient in KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is ketotifen. This information helps identify medicines with the same composition but different brand names.

Who manufactures KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?

KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Nutra Essential Otc S.L.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to KETOTIFEN DERMOGEN 0.25 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?

Other medicines with the same active substance (ketotifen) include BENTIFEN 0.25mg/ml EYE DROPS SOLUTION, KETISAL 0.25 mg/ml EYE DROPS SOLUTION, KETOBRILL 0.25 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media